missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human ASNA1 (aa 248-343) Control Fragment Recombinant Protein
missing translation for 'orderingAttributeHoverText'
Quantity:
100 μL
missing translation for 'unitSize'
100µL
Description
Highest antigen sequence indentity to the following orthologs: Mouse (100%), Rat (100%). This recombinant protein control fragment may be used for blocking experiments with the corresponding antibody, PA5-83801 (PA5-83801. In IHC/ICC and WB experiments, we recommend a 100x molar excess of the protein fragment control based on the concentration and the molecular weight. Pre-incubate the antibody-protein control fragment mixture for 30 min at room temperature.
ASNA1 is the human homolog of the bacterial arsA gene. In E. coli, ArsA ATPase is the catalytic component of a multisubunit oxyanion pump that is responsible for resistance to arsenicals and antimonials.
Specifications
Specifications
| Accession Number | O43681 |
| Concentration | ≥5.0 mg/mL |
| For Use With (Application) | Blocking Assay, Control |
| Formulation | 1 M urea, PBS with no preservative; pH 7.4 |
| Gene ID (Entrez) | 439 |
| Name | Human ASNA1 (aa 248-343) Control Fragment |
| Quantity | 100 μL |
| Regulatory Status | RUO |
| Gene Alias | 1810048H22Rik; ARSA; arsA arsenite transporter, ATP-binding, homolog 1; arsA arsenite transporter, ATP-binding, homolog 1 (bacterial); ARSA1; ARSA-I; Arsenical pump-driving ATPase; Arsenical resistance ATPase; arsenite-stimulated ATPase; arsenite-translocating ATPase; Arsenite-transporting ATPase; asna1; ASNA-I; ATPase asna1; ATPase GET3; GET3; guided entry of tail-anchored proteins factor 3, ATPase; hARSA-I; hASNA-I; MGC3821; si:dkey-121b10.2; Transmembrane domain recognition complex 40 kDa ATPase subunit; TRC40; wu:fd05d03; zgc:56540; zgc:56540 protein; zgc:86799 |
| Common Name | ASNA1 |
| Show More |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction